← Eli Lilly and Company
Episodes featuring Eli Lilly and Company
342 episodes, newest first.
- Nov 16, 2026
Prepare for a crash without abandoning the marketRich Habits PodcastNov 16, 2026 - Nov 15, 2026
Biotech investors weigh gene editing, MASH data and RAS riskBreaking BiotechNov 15, 2026 - Nov 14, 2026
Conviction demands deeper research than microcap confidencePlanet MicroCap Podcast | MicroCap Investing StrategiesNov 14, 2026 - Nov 14, 2026
Cramer turns Wall Street jargon into portfolio decisionsMad Money w/ Jim CramerNov 14, 2026 - Nov 13, 2026
AI financing risks collide with Nvidia leadership uncertaintyClosing BellNov 13, 2026 - Nov 13, 2026
Biotech launches expose the gap between forecasts and adoptionBiotech HangoutNov 13, 2026 - Nov 13, 2026
Scarce capital creates openings in overlooked ASX small capsThe Rules of InvestingNov 13, 2026 - Nov 13, 2026
Supplement quality and consistency shape thyroid outcomesThe Thyroid (and Hormone) Fixer Podcast: Thyropause, Menopause, Metabolism and How to Fix ItNov 13, 2026 - Nov 12, 2026
Nvidia shock exposes fragile foundations beneath the AI tradeCNBC's "Fast Money"Nov 12, 2026 - Nov 12, 2026
Biotech’s uncertainty creates disciplined investment opportunitiesThe Acquirers PodcastNov 12, 2026 - Nov 11, 2026
Ro bets healthcare’s future on patient demand and softwareInvest Like the Best with Patrick O'ShaughnessyNov 11, 2026 - Nov 11, 2026
Carb cycling improves dieting without unlocking special fat lossMind Pump: Raw Fitness TruthNov 11, 2026 - Nov 10, 2026
Gotham’s semifinal move exposes NWSL infrastructure gapsGood Game with Sarah SpainNov 10, 2026 - Nov 10, 2026
Nvidia faces key-person and national-security risksCNBC's "Fast Money"Nov 10, 2026 - Nov 10, 2026
Nvidia scrutiny tests corporate accountability and national securityPBS News Hour - Full ShowNov 10, 2026 - Nov 9, 2026
Nvidia stumbles as investors rotate beyond AIClosing BellNov 9, 2026 - Nov 9, 2026
Nvidia’s China exposure collides with national-security scrutinyClosing BellNov 9, 2026 - Nov 9, 2026
Nvidia’s uncertainty exposes pressure points across AI and healthcareWSJ What’s NewsNov 9, 2026 - Nov 9, 2026
NVIDIA faces governance risk as Tesla pivots to robotaxisBrew MarketsNov 9, 2026 - Nov 9, 2026
AI’s next fortune may come from the physical worldMy First MillionNov 9, 2026 - Nov 9, 2026
AbbVie builds a risk-managed neuroscience portfolioBusiness Of BiotechNov 9, 2026 - Nov 8, 2026
Growth investors reassess AI bets and portfolio resilienceEquity Mates Investing PodcastNov 8, 2026 - Nov 8, 2026
Three stocks face defining tests in the week aheadStock MoversNov 8, 2026 - Nov 7, 2026
Bitcoin challenges AI stocks as market risks multiplyThe Pomp PodcastNov 7, 2026